Open access · CC-BY
via OpenAlex
Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype
Sally K. Y. To, Yibin Yang, Zeyu Shi, K. Fung, Sook Ling Lai, Joshua J. X. Li, Philip P.C. Ip, Alice S.T. Wong
Cell Death and Disease · 2026
Abstract
Intratumoral heterogeneity in metastatic cancers complicates effective treatment, as distinct tumor subclones display varying drug sensitivities and metastatic capabilities, interacting through mechanisms that remain poorly understood. In this study, we utilized an isogenic ovarian cancer cell pair distinguished by differential β-catenin signaling: non-metastatic (NM) cells with low β-catenin and highly metastatic (HM) cells with elevated β-catenin signaling. Co-engrafting NM and HM cells synergistically enhances peritoneal metastasis compared to either subclone alone. Immunohistochemical analysis revealed a mosaic β-catenin expression in mixed tumors, recapitulating the heterogeneity observed in clinical ovarian cancer cases. Notably, both NM cells and β-catenin-knockout HM cells exhibited an intrinsic senescence(definition)-associated secretory phenotype (SASP), mechanistically driven by Hippo/YAP signaling, which was suppressed by β-catenin in HM cells. This phenotype in turn facilitated the metastatic dissemination of β-catenin-high subclones through paracrine signaling. Importantly, mixed in vivo tumors were more susceptible to treatment with fisetin, a senolytic agent, and YAP inhibition, leading to marked reduction in metastatic burden. Overall, our findings demonstrate the pre-existence of senescence-like tumor cells in untreated conditions and reveal a novel cooperative mechanism in which β-catenin heterogeneity facilitates ovarian cancer progression through SASP-mediated subclonal interactions. These results provide a basis for targeted therapeutic strategies to disrupt intratumoral communication and improve treatment outcomes in metastatic ovarian cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41419-026-08737-7
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
To, S.K.Y., Yang, Y., Shi, Z., Fung, K., Lai, S.L., Li, J.J.X., Ip, P.P., & Wong, A.S. (2026). Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype. <em>Cell Death and Disease</em>. https://doi.org/10.1038/s41419-026-08737-7
Vancouver
To SKY, Yang Y, Shi Z, Fung K, Lai SL, Li JJX, et al. Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype. Cell Death and Disease. 2026. doi:10.1038/s41419-026-08737-7.
BibTeX
@article{sally2026Subclo,
title = {Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype},
author = {Sally K. Y. To and Yibin Yang and Zeyu Shi and K. Fung and Sook Ling Lai and Joshua J. X. Li and Philip P.C. Ip and Alice S.T. Wong},
journal = {Cell Death and Disease},
year = {2026},
doi = {10.1038/s41419-026-08737-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomedicine & Pharmacotherapy 2024
Open access · CC-BY
Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer
Cells 2019
Open access · CC-BY
Gap Junction Intercellular Communication in the Carcinogenesis Hallmarks: Is This a Phenomenon or Epiphenomenon?
Intrinsically Disordered Proteins 2014
Open access · OA
The development of a malignant tumor is due to a desperate asexual self-cloning process in which cancer stem cells develop the ability to mimic the genetic program of germline cells
Cells 2026
Open access · OA
Fate Bifurcation of Cellular Senescence: Dynamic Regulation from Tumor Suppression to Recurrence Risk.
Cell Communication and Signaling 2018
Open access · CC-BY
MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells
Cancer Cell 2025
Open access · CC-BY